J CLIN ONCOL 润色咨询

JOURNAL OF CLINICAL ONCOLOGY

出版年份：1983 年文章数：3980 投稿命中率： 开通期刊会员，数据随心看

出版周期：Biweekly 自引率：3.2% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=493259, encodeId=f9f649325990, content=向J CO 进发中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=502, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 03 20:04:00 CST 2013, time=2013-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491645, encodeId=9b6b491645f2, content=2012年11月投了一篇，还在under review中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Nov 27 16:13:00 CST 2012, time=2012-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=490476, encodeId=0a6d4904e606, content=8月16日投递了一篇文章，现在快一个月了，处于评审状态，期待中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf4867545, createdName=ldyyboyue, createdTime=Mon Sep 10 08:56:00 CST 2012, time=2012-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486893, encodeId=5c13486893d1, content=喔这么高，努力一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71ba17440, createdName=zhouyunzhoush, createdTime=Thu Feb 23 21:21:00 CST 2012, time=2012-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483131, encodeId=f7db483131c9, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Jul 03 11:23:00 CST 2011, time=2011-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482280, encodeId=df4648228048, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=452, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:19:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474361, encodeId=e3eb4e43618e, content=审稿速度:2.0 | 投稿命中率:20.0<br>经验分享：很难中！这个杂志在肿瘤领域，这几年发展还是相当迅速的。投被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=601, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=oncogen, createdTime=Thu Mar 10 19:20:00 CST 2011, time=2011-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473532, encodeId=648f4e3532ca, content=努力试一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jan 25 17:30:00 CST 2011, time=2011-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472146, encodeId=fad34e21460e, content=努力准备发一篇 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Oct 16 20:01:00 CST 2010, time=2010-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=471999, encodeId=6dd34e1999e5, content=努力发一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=588, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jco, createdTime=Mon Oct 04 22:30:00 CST 2010, time=2010-10-04, status=1, ipAttribution=)]
    2013-01-03 匿名用户

    向J CO 进发中

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=493259, encodeId=f9f649325990, content=向J CO 进发中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=502, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 03 20:04:00 CST 2013, time=2013-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491645, encodeId=9b6b491645f2, content=2012年11月投了一篇，还在under review中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Nov 27 16:13:00 CST 2012, time=2012-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=490476, encodeId=0a6d4904e606, content=8月16日投递了一篇文章，现在快一个月了，处于评审状态，期待中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf4867545, createdName=ldyyboyue, createdTime=Mon Sep 10 08:56:00 CST 2012, time=2012-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486893, encodeId=5c13486893d1, content=喔这么高，努力一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71ba17440, createdName=zhouyunzhoush, createdTime=Thu Feb 23 21:21:00 CST 2012, time=2012-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483131, encodeId=f7db483131c9, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Jul 03 11:23:00 CST 2011, time=2011-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482280, encodeId=df4648228048, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=452, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:19:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474361, encodeId=e3eb4e43618e, content=审稿速度:2.0 | 投稿命中率:20.0<br>经验分享：很难中！这个杂志在肿瘤领域，这几年发展还是相当迅速的。投被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=601, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=oncogen, createdTime=Thu Mar 10 19:20:00 CST 2011, time=2011-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473532, encodeId=648f4e3532ca, content=努力试一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jan 25 17:30:00 CST 2011, time=2011-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472146, encodeId=fad34e21460e, content=努力准备发一篇 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Oct 16 20:01:00 CST 2010, time=2010-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=471999, encodeId=6dd34e1999e5, content=努力发一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=588, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jco, createdTime=Mon Oct 04 22:30:00 CST 2010, time=2010-10-04, status=1, ipAttribution=)]
    2012-11-27 匿名用户

    2012年11月投了一篇，还在under review中

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=493259, encodeId=f9f649325990, content=向J CO 进发中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=502, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 03 20:04:00 CST 2013, time=2013-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491645, encodeId=9b6b491645f2, content=2012年11月投了一篇，还在under review中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Nov 27 16:13:00 CST 2012, time=2012-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=490476, encodeId=0a6d4904e606, content=8月16日投递了一篇文章，现在快一个月了，处于评审状态，期待中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf4867545, createdName=ldyyboyue, createdTime=Mon Sep 10 08:56:00 CST 2012, time=2012-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486893, encodeId=5c13486893d1, content=喔这么高，努力一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71ba17440, createdName=zhouyunzhoush, createdTime=Thu Feb 23 21:21:00 CST 2012, time=2012-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483131, encodeId=f7db483131c9, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Jul 03 11:23:00 CST 2011, time=2011-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482280, encodeId=df4648228048, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=452, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:19:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474361, encodeId=e3eb4e43618e, content=审稿速度:2.0 | 投稿命中率:20.0<br>经验分享：很难中！这个杂志在肿瘤领域，这几年发展还是相当迅速的。投被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=601, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=oncogen, createdTime=Thu Mar 10 19:20:00 CST 2011, time=2011-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473532, encodeId=648f4e3532ca, content=努力试一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jan 25 17:30:00 CST 2011, time=2011-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472146, encodeId=fad34e21460e, content=努力准备发一篇 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Oct 16 20:01:00 CST 2010, time=2010-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=471999, encodeId=6dd34e1999e5, content=努力发一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=588, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jco, createdTime=Mon Oct 04 22:30:00 CST 2010, time=2010-10-04, status=1, ipAttribution=)]
    2012-09-10 ldyyboyue

    8月16日投递了一篇文章，现在快一个月了，处于评审状态，期待中！

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=493259, encodeId=f9f649325990, content=向J CO 进发中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=502, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 03 20:04:00 CST 2013, time=2013-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491645, encodeId=9b6b491645f2, content=2012年11月投了一篇，还在under review中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Nov 27 16:13:00 CST 2012, time=2012-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=490476, encodeId=0a6d4904e606, content=8月16日投递了一篇文章，现在快一个月了，处于评审状态，期待中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf4867545, createdName=ldyyboyue, createdTime=Mon Sep 10 08:56:00 CST 2012, time=2012-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486893, encodeId=5c13486893d1, content=喔这么高，努力一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71ba17440, createdName=zhouyunzhoush, createdTime=Thu Feb 23 21:21:00 CST 2012, time=2012-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483131, encodeId=f7db483131c9, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Jul 03 11:23:00 CST 2011, time=2011-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482280, encodeId=df4648228048, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=452, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:19:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474361, encodeId=e3eb4e43618e, content=审稿速度:2.0 | 投稿命中率:20.0<br>经验分享：很难中！这个杂志在肿瘤领域，这几年发展还是相当迅速的。投被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=601, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=oncogen, createdTime=Thu Mar 10 19:20:00 CST 2011, time=2011-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473532, encodeId=648f4e3532ca, content=努力试一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jan 25 17:30:00 CST 2011, time=2011-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472146, encodeId=fad34e21460e, content=努力准备发一篇 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Oct 16 20:01:00 CST 2010, time=2010-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=471999, encodeId=6dd34e1999e5, content=努力发一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=588, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jco, createdTime=Mon Oct 04 22:30:00 CST 2010, time=2010-10-04, status=1, ipAttribution=)]
    2012-02-23 zhouyunzhoush

    喔这么高，努力一下

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=493259, encodeId=f9f649325990, content=向J CO 进发中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=502, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 03 20:04:00 CST 2013, time=2013-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491645, encodeId=9b6b491645f2, content=2012年11月投了一篇，还在under review中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Nov 27 16:13:00 CST 2012, time=2012-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=490476, encodeId=0a6d4904e606, content=8月16日投递了一篇文章，现在快一个月了，处于评审状态，期待中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf4867545, createdName=ldyyboyue, createdTime=Mon Sep 10 08:56:00 CST 2012, time=2012-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486893, encodeId=5c13486893d1, content=喔这么高，努力一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71ba17440, createdName=zhouyunzhoush, createdTime=Thu Feb 23 21:21:00 CST 2012, time=2012-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483131, encodeId=f7db483131c9, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Jul 03 11:23:00 CST 2011, time=2011-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482280, encodeId=df4648228048, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=452, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:19:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474361, encodeId=e3eb4e43618e, content=审稿速度:2.0 | 投稿命中率:20.0<br>经验分享：很难中！这个杂志在肿瘤领域，这几年发展还是相当迅速的。投被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=601, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=oncogen, createdTime=Thu Mar 10 19:20:00 CST 2011, time=2011-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473532, encodeId=648f4e3532ca, content=努力试一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jan 25 17:30:00 CST 2011, time=2011-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472146, encodeId=fad34e21460e, content=努力准备发一篇 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Oct 16 20:01:00 CST 2010, time=2010-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=471999, encodeId=6dd34e1999e5, content=努力发一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=588, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jco, createdTime=Mon Oct 04 22:30:00 CST 2010, time=2010-10-04, status=1, ipAttribution=)]
    2011-07-03 匿名用户

    偏重的研究方向：肿瘤;癌症;

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=493259, encodeId=f9f649325990, content=向J CO 进发中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=502, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 03 20:04:00 CST 2013, time=2013-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491645, encodeId=9b6b491645f2, content=2012年11月投了一篇，还在under review中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Nov 27 16:13:00 CST 2012, time=2012-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=490476, encodeId=0a6d4904e606, content=8月16日投递了一篇文章，现在快一个月了，处于评审状态，期待中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf4867545, createdName=ldyyboyue, createdTime=Mon Sep 10 08:56:00 CST 2012, time=2012-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486893, encodeId=5c13486893d1, content=喔这么高，努力一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71ba17440, createdName=zhouyunzhoush, createdTime=Thu Feb 23 21:21:00 CST 2012, time=2012-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483131, encodeId=f7db483131c9, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Jul 03 11:23:00 CST 2011, time=2011-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482280, encodeId=df4648228048, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=452, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:19:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474361, encodeId=e3eb4e43618e, content=审稿速度:2.0 | 投稿命中率:20.0<br>经验分享：很难中！这个杂志在肿瘤领域，这几年发展还是相当迅速的。投被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=601, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=oncogen, createdTime=Thu Mar 10 19:20:00 CST 2011, time=2011-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473532, encodeId=648f4e3532ca, content=努力试一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jan 25 17:30:00 CST 2011, time=2011-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472146, encodeId=fad34e21460e, content=努力准备发一篇 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Oct 16 20:01:00 CST 2010, time=2010-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=471999, encodeId=6dd34e1999e5, content=努力发一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=588, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jco, createdTime=Mon Oct 04 22:30:00 CST 2010, time=2010-10-04, status=1, ipAttribution=)]
    2011-06-29 neuron2010

    偏重的研究方向：肿瘤;癌症;

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=493259, encodeId=f9f649325990, content=向J CO 进发中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=502, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 03 20:04:00 CST 2013, time=2013-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491645, encodeId=9b6b491645f2, content=2012年11月投了一篇，还在under review中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Nov 27 16:13:00 CST 2012, time=2012-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=490476, encodeId=0a6d4904e606, content=8月16日投递了一篇文章，现在快一个月了，处于评审状态，期待中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf4867545, createdName=ldyyboyue, createdTime=Mon Sep 10 08:56:00 CST 2012, time=2012-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486893, encodeId=5c13486893d1, content=喔这么高，努力一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71ba17440, createdName=zhouyunzhoush, createdTime=Thu Feb 23 21:21:00 CST 2012, time=2012-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483131, encodeId=f7db483131c9, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Jul 03 11:23:00 CST 2011, time=2011-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482280, encodeId=df4648228048, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=452, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:19:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474361, encodeId=e3eb4e43618e, content=审稿速度:2.0 | 投稿命中率:20.0<br>经验分享：很难中！这个杂志在肿瘤领域，这几年发展还是相当迅速的。投被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=601, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=oncogen, createdTime=Thu Mar 10 19:20:00 CST 2011, time=2011-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473532, encodeId=648f4e3532ca, content=努力试一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jan 25 17:30:00 CST 2011, time=2011-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472146, encodeId=fad34e21460e, content=努力准备发一篇 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Oct 16 20:01:00 CST 2010, time=2010-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=471999, encodeId=6dd34e1999e5, content=努力发一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=588, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jco, createdTime=Mon Oct 04 22:30:00 CST 2010, time=2010-10-04, status=1, ipAttribution=)]
    2011-03-10 oncogen

    审稿速度:2.0 | 投稿命中率:20.0
    经验分享：很难中！这个杂志在肿瘤领域，这几年发展还是相当迅速的。投被拒了

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=493259, encodeId=f9f649325990, content=向J CO 进发中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=502, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 03 20:04:00 CST 2013, time=2013-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491645, encodeId=9b6b491645f2, content=2012年11月投了一篇，还在under review中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Nov 27 16:13:00 CST 2012, time=2012-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=490476, encodeId=0a6d4904e606, content=8月16日投递了一篇文章，现在快一个月了，处于评审状态，期待中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf4867545, createdName=ldyyboyue, createdTime=Mon Sep 10 08:56:00 CST 2012, time=2012-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486893, encodeId=5c13486893d1, content=喔这么高，努力一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71ba17440, createdName=zhouyunzhoush, createdTime=Thu Feb 23 21:21:00 CST 2012, time=2012-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483131, encodeId=f7db483131c9, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Jul 03 11:23:00 CST 2011, time=2011-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482280, encodeId=df4648228048, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=452, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:19:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474361, encodeId=e3eb4e43618e, content=审稿速度:2.0 | 投稿命中率:20.0<br>经验分享：很难中！这个杂志在肿瘤领域，这几年发展还是相当迅速的。投被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=601, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=oncogen, createdTime=Thu Mar 10 19:20:00 CST 2011, time=2011-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473532, encodeId=648f4e3532ca, content=努力试一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jan 25 17:30:00 CST 2011, time=2011-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472146, encodeId=fad34e21460e, content=努力准备发一篇 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Oct 16 20:01:00 CST 2010, time=2010-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=471999, encodeId=6dd34e1999e5, content=努力发一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=588, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jco, createdTime=Mon Oct 04 22:30:00 CST 2010, time=2010-10-04, status=1, ipAttribution=)]
    2011-01-25 匿名用户

    努力试一试

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=493259, encodeId=f9f649325990, content=向J CO 进发中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=502, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 03 20:04:00 CST 2013, time=2013-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491645, encodeId=9b6b491645f2, content=2012年11月投了一篇，还在under review中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Nov 27 16:13:00 CST 2012, time=2012-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=490476, encodeId=0a6d4904e606, content=8月16日投递了一篇文章，现在快一个月了，处于评审状态，期待中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf4867545, createdName=ldyyboyue, createdTime=Mon Sep 10 08:56:00 CST 2012, time=2012-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486893, encodeId=5c13486893d1, content=喔这么高，努力一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71ba17440, createdName=zhouyunzhoush, createdTime=Thu Feb 23 21:21:00 CST 2012, time=2012-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483131, encodeId=f7db483131c9, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Jul 03 11:23:00 CST 2011, time=2011-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482280, encodeId=df4648228048, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=452, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:19:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474361, encodeId=e3eb4e43618e, content=审稿速度:2.0 | 投稿命中率:20.0<br>经验分享：很难中！这个杂志在肿瘤领域，这几年发展还是相当迅速的。投被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=601, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=oncogen, createdTime=Thu Mar 10 19:20:00 CST 2011, time=2011-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473532, encodeId=648f4e3532ca, content=努力试一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jan 25 17:30:00 CST 2011, time=2011-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472146, encodeId=fad34e21460e, content=努力准备发一篇 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Oct 16 20:01:00 CST 2010, time=2010-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=471999, encodeId=6dd34e1999e5, content=努力发一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=588, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jco, createdTime=Mon Oct 04 22:30:00 CST 2010, time=2010-10-04, status=1, ipAttribution=)]
    2010-10-16 匿名用户

    努力准备发一篇

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=493259, encodeId=f9f649325990, content=向J CO 进发中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=502, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 03 20:04:00 CST 2013, time=2013-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491645, encodeId=9b6b491645f2, content=2012年11月投了一篇，还在under review中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Nov 27 16:13:00 CST 2012, time=2012-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=490476, encodeId=0a6d4904e606, content=8月16日投递了一篇文章，现在快一个月了，处于评审状态，期待中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf4867545, createdName=ldyyboyue, createdTime=Mon Sep 10 08:56:00 CST 2012, time=2012-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486893, encodeId=5c13486893d1, content=喔这么高，努力一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71ba17440, createdName=zhouyunzhoush, createdTime=Thu Feb 23 21:21:00 CST 2012, time=2012-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483131, encodeId=f7db483131c9, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Jul 03 11:23:00 CST 2011, time=2011-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482280, encodeId=df4648228048, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=452, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:19:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474361, encodeId=e3eb4e43618e, content=审稿速度:2.0 | 投稿命中率:20.0<br>经验分享：很难中！这个杂志在肿瘤领域，这几年发展还是相当迅速的。投被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=601, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=oncogen, createdTime=Thu Mar 10 19:20:00 CST 2011, time=2011-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473532, encodeId=648f4e3532ca, content=努力试一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jan 25 17:30:00 CST 2011, time=2011-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472146, encodeId=fad34e21460e, content=努力准备发一篇 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Oct 16 20:01:00 CST 2010, time=2010-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=471999, encodeId=6dd34e1999e5, content=努力发一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=588, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jco, createdTime=Mon Oct 04 22:30:00 CST 2010, time=2010-10-04, status=1, ipAttribution=)]
    2010-10-04 jco

    努力发一篇

    0

共87条页码: 6/9页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分